Back to Search
Start Over
Protease-antiprotease imbalance in patients with severe COVID-19
- Source :
- Clinical Chemistry and Laboratory Medicine, Clinical Chemistry and Laboratory Medicine, 2021, 59 (8), pp.e330-e334. ⟨10.1515/cclm-2021-0137⟩, Clinical Chemistry and Laboratory Medicine, De Gruyter, 2021, 59 (8), pp.e330-e334. ⟨10.1515/cclm-2021-0137⟩
- Publication Year :
- 2021
- Publisher :
- Walter de Gruyter GmbH, 2021.
-
Abstract
- International audience; No abstract available
- Subjects :
- Adult
Male
ARDS
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
[SDV]Life Sciences [q-bio]
medicine.medical_treatment
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Clinical Biochemistry
Enzyme-Linked Immunosorbent Assay
Severity of Illness Index
alpha-1 antitrypsin
COVID-19
elastase
matrix metalloprotease-12 (MMP-12)
03 medical and health sciences
0302 clinical medicine
Matrix Metalloproteinase 12
Severity of illness
medicine
Humans
In patient
ComputingMilieux_MISCELLANEOUS
Aged
030304 developmental biology
0303 health sciences
Protease
SARS-CoV-2
business.industry
Biochemistry (medical)
Elastase
General Medicine
Middle Aged
medicine.disease
3. Good health
[SDV] Life Sciences [q-bio]
Intensive Care Units
030228 respiratory system
alpha 1-Antitrypsin
Immunology
Female
Leukocyte Elastase
business
Bronchoalveolar Lavage Fluid
Subjects
Details
- ISSN :
- 14374331 and 14346621
- Volume :
- 59
- Database :
- OpenAIRE
- Journal :
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Accession number :
- edsair.doi.dedup.....9078dd1872d42ce18131de370d999bf3